Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News
Tag Archives: Center for Drug Evaluation and Research
Woodcock Under Investigation
Image by Getty Images via Daylife
An FDA director has come under fire by a generics firm claiming that the director of the Center for Drug Evaluation and Research favored a competitor in a wanton act of conflict of interest. The Wall Street Journal this morning broke the story that Janet Woodcock is under investigation by [...]
Posted in Strategy Also tagged Amphastar, FDA, Food and Drug Administration, Sandoz, U.S. Food and Drug Administration, Wall Street Journal Leave a comment
FDA Panel Calls for Ban on Narcotic/Tylenol Combo Drugs
Image via Wikipedia
A joint committee of three FDA advisory groups voted on Tuesday to recommend the elimination of prescription combination drugs containing acetaminophen due to a spike in instances of liver-induced toxicity.
The panel of experts, physicians, and regulators voted 20 to 17 in favor of banning acetaminophen combo drugs such as Vicodin and Percocet. They [...]
Posted in Regulatory, Safety Also tagged acetaminophen, Drug overdose, FDA, Health, liver toxicity, overdose, Paracetamol, percocet, Prescription drug, U.S. Food and Drug Administration, Vicodin 1 Comment

Adverse Event Reports Go Digital Only